US Patent Issued to MITOIMMUNE THERAPEUTICS on June 9 for "Crystalline forms of 5-[(1,1-dioxido-4-thiomorpholinyl)methyl-2-phenyl-N-(tetrahydro-2H-pyran-4-yl)-1H-indol-7-amine" (South Korean Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,730, issued on June 9, was assigned to MITOIMMUNE THERAPEUTICS INC. (Seoul, South Korea).

"Crystalline forms of 5-[(1,1-dioxido-4-thiomorpholinyl)methyl-2-phenyl-N-(tetrahydro-2H-pyran-4-yl)-1H-indol-7-amine" was invented by Soon Ha Kim (Seoul, South Korea), Hye Kyung Chang (Seoul, South Korea), Hyoung Jin Kim (Seoul, South Korea), Sae Yeon Lee (Seoul, South Korea), Sang Kweon Jeon (Seoul, South Korea), Eun Kyung Yoo (Seoul, South Korea) and Mooyoung Seo (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a Crystalline Form A of a compound of Chemical Formula 1 having physically and chemically outstandi...